Funding, News and Announcements

Under the AMR initiative, CIHR has launched the Antimicrobial Resistance: Point of Care (POC) Diagnostics in Human Health program. Phase 1 aimed to advance innovative AMR point-of-care diagnostics closer to a stage of clinical readiness; five teams were funded. CIHR is now launching a Phase 2 open competition, which aims to further accelerate development of technologies or tools that have passed the preliminary design developmental phase.

This funding opportunity is open to all applicants, provided they meet all of the eligibility criteria and submit an application relevant to the objectives and relevant research areas. It is not a prerequisite to have Phase 1 funding in order to apply to Phase 2.

The total amount available for this funding opportunity is $2,025,000, enough to fund approximately 3 grants. The maximum amount per grant is $225,000 per year for up to 3 years for a total of $675,000 per grant. Applicants must secure eligible partner contributions (cash or in-kind) to match the CIHR contribution at a minimum of 1:1 ratio. 

For full program details, please consult the website. 

Please address your questions to David.Spurrell@dal.ca or Christine.Whitehouse@dal.ca.

Internal Deadline: August 15, 2018
Agency Deadline: August 21, 2018